NCT03292965View on ClinicalTrials.gov

Monitoring of Postoperative Residual Neuromuscular Blockade in Laparoscopic Surgery

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 28, 2017

Primary Completion Date

November 29, 2017

Study Completion Date

November 29, 2017

Conditions
Neuromuscular Block, Residual
Interventions
DRUG

Neostigmine

Referring to the randomisation allocation program, participants allocated to group neostigmine, administrate neostigmine as reversal

DRUG

Sugammadex

Referring to the randomisation allocation program, participants allocated to group sugammadex, administrate sugammadex as reversal

Trial Locations (1)

13620

Seoul National University Bundang Hospital, Seongnam-si

All Listed Sponsors
lead

Seoul National University Bundang Hospital

OTHER

NCT03292965 - Monitoring of Postoperative Residual Neuromuscular Blockade in Laparoscopic Surgery | Biotech Hunter | Biotech Hunter